Letter

C reactive protein and acute phase of ischaemic stroke

BMJ 2001; 322 doi: 10.1136/bmj.322.7302.1605/a (Published 30 June 2001)
Cite this as: BMJ 2001;322:1605.2

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Mario Di Napoli, consultant neurologist (mariodinapoli@katamail.com)
  1. Department of Neurology and Neurorehabilitation, Casa di Cura Villa Pini d'Abruzzo, 661080 Chieti, Italy

    EDITOR—Higher C reactive protein concentrations indicate increased risk of coronary and cerebrovascular events in otherwise healthy individuals1 and a worse prognosis in myocardial infarction2 and ischaemic stroke.3 According to Pepys and Berger, the available data support its potential role as a marker of cardiovascular risk.4 To be of clinical use, however, the protein must have an independent prognostic value over and above that of the data already routinely available.

    In patients with acute myocardial infarction or ischaemic stroke the extent of …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    Read related article

    See previous polls

    BMJ most popular